The Homeobox gene, HOXB13, Regulates a Mitotic Protein-Kinase Interaction Network in Metastatic Prostate Cancers.
Apoptosis
Biomarkers, Tumor
/ genetics
Cell Movement
Cell Proliferation
Gene Expression Regulation, Neoplastic
Homeodomain Proteins
/ genetics
Humans
Male
Middle Aged
Neoplasm Metastasis
Prostatectomy
Prostatic Neoplasms
/ genetics
Protein Interaction Maps
Receptors, Androgen
/ genetics
Signal Transduction
Tumor Cells, Cultured
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
04 07 2019
04 07 2019
Historique:
received:
04
01
2019
accepted:
18
06
2019
entrez:
6
7
2019
pubmed:
6
7
2019
medline:
27
10
2020
Statut:
epublish
Résumé
HOXB13, a homeodomain transcription factor, is linked to recurrence following radical prostatectomy. While HOXB13 regulates Androgen Receptor (AR) functions in a context dependent manner, its critical effectors in prostate cancer (PC) metastasis remain largely unknown. To identify HOXB13 transcriptional targets in metastatic PCs, we performed integrative bioinformatics analysis of differentially expressed genes (DEGs) in the proximity of the human prostate tumor-specific AR binding sites. Unsupervised Principal Component Analysis (PCA) led to a focused core HOXB13 target gene-set referred to as HOTPAM9 (HOXB13 Targets separating Primary And Metastatic PCs). HOTPAM9 comprised 7 mitotic kinase genes overexpressed in metastatic PCs, TRPM8, and the heat shock protein HSPB8, whose levels were significantly lower in metastatic PCs compared to the primary disease. The expression of a two-gene set, CIT and HSPB8 with an overall balanced accuracy of 98.8% and a threshold value of 0.2347, was sufficient to classify metastasis. HSPB8 mRNA expression was significantly increased following HOXB13 depletion in multiple metastatic CRPC models. Increased expression of HSPB8 by the microtubule inhibitor Colchicine or by exogenous means suppressed migration of mCRPC cells. Collectively, our results indicate that HOXB13 promotes metastasis of PCs by coordinated regulation of mitotic kinases and blockade of a putative tumor suppressor gene.
Identifiants
pubmed: 31273254
doi: 10.1038/s41598-019-46064-4
pii: 10.1038/s41598-019-46064-4
pmc: PMC6609629
doi:
Substances chimiques
AR protein, human
0
Biomarkers, Tumor
0
HOXB13 protein, human
0
Homeodomain Proteins
0
Receptors, Androgen
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
9715Subventions
Organisme : NCI NIH HHS
ID : P30 CA076292
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA091842
Pays : United States
Références
Cancer Discov. 2017 Jul;7(7):736-749
pubmed: 28411207
APMIS. 2016 Mar;124(3):188-93
pubmed: 26590121
Am J Epidemiol. 2006 Apr 1;163(7):670-5
pubmed: 16410346
J Biol Chem. 2003 Sep 26;278(39):37600-9
pubmed: 12832417
Nat Genet. 2015 Nov;47(11):1346-51
pubmed: 26457646
BMC Urol. 2015 Aug 29;15:90
pubmed: 26320076
Oncol Lett. 2016 Jan;11(1):182-188
pubmed: 26870186
Oncol Lett. 2015 Sep;10(3):1378-1384
pubmed: 26622677
Mo Med. 2018 Mar-Apr;115(2):131
pubmed: 30228703
Am Soc Clin Oncol Educ Book. 2016;35:131-41
pubmed: 27249694
Oncoscience. 2016 Oct 31;3(9-10):288-296
pubmed: 28050579
Am J Surg Pathol. 2014 May;38(5):615-26
pubmed: 24722062
BMC Cancer. 2007 Apr 12;7:64
pubmed: 17430594
Cell. 2009 Jul 23;138(2):245-56
pubmed: 19632176
Neurobiol Aging. 2013 Nov;34(11):2585-603
pubmed: 23810450
Prostate. 1999 Nov 1;41(3):203-7
pubmed: 10517879
J Clin Invest. 2019 Jan 2;129(1):192-208
pubmed: 30334814
Oncotarget. 2016 Dec 27;7(52):87323-87341
pubmed: 27895316
Cancer Cell. 2010 Jul 13;18(1):11-22
pubmed: 20579941
Br J Cancer. 2005 Jan 31;92(2):376-81
pubmed: 15583692
Oncotarget. 2017 Jun 27;8(42):71954-71964
pubmed: 29069760
Mol Cancer Ther. 2018 Dec;17(12):2796-2810
pubmed: 30242092
Mol Cancer Res. 2019 Feb;17(2):476-487
pubmed: 30401717
Cancer Lett. 2006 Jun 18;237(2):155-66
pubmed: 16084011
Cancer Res. 2004 Dec 15;64(24):9185-92
pubmed: 15604291
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):6810-6815
pubmed: 29844167
Development. 2013 Oct;140(19):3951-63
pubmed: 24046316
Eur Urol. 2013 Oct;64(4):577-8
pubmed: 23778019
Nat Rev Cancer. 2010 May;10(5):361-71
pubmed: 20357775
Exp Mol Pathol. 2010 Apr;88(2):225-33
pubmed: 20034488
Cancer Cell. 2017 Jun 12;31(6):790-803.e8
pubmed: 28609657
Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1366-72
pubmed: 26108461
Mol Cell. 2009 Nov 13;36(3):405-16
pubmed: 19917249
Nature. 2012 Jul 12;487(7406):239-43
pubmed: 22722839
Eur Urol. 2017 May;71(5):776-787
pubmed: 27497761
Cancer Metastasis Rev. 2015 Dec;34(4):703-13
pubmed: 26358854
Nat Med. 2016 Mar;22(3):298-305
pubmed: 26855148
Cancer Cell. 2005 Nov;8(5):393-406
pubmed: 16286247
Nature. 2014 Jun 12;510(7504):278-82
pubmed: 24759320
Oncogene. 2014 Sep 11;33(37):4558-67
pubmed: 24096478
Anat Cell Biol. 2010 Dec;43(4):284-93
pubmed: 21267402
Nature. 2001 Aug 23;412(6849):822-6
pubmed: 11518967
Open Biol. 2016 Mar;6(3):
pubmed: 27009191
Mol Cancer. 2010 May 27;9:124
pubmed: 20504375
Sci Rep. 2016 Mar 10;6:22827
pubmed: 26961006
Oncogene. 2007 May 24;26(24):3521-31
pubmed: 17173073
Science. 2018 Oct 5;362(6410):91-95
pubmed: 30287662
J Biol Chem. 2003 Dec 19;278(51):51786-95
pubmed: 14523000
Oncotarget. 2017 Feb 7;8(6):10400-10415
pubmed: 28060751
PLoS One. 2012;7(6):e38950
pubmed: 22761715
Development. 2003 May;130(10):2061-9
pubmed: 12668621
Virchows Arch. 2016 Jul;469(1):119-20
pubmed: 27125649
Mol Cancer Res. 2018 Apr;16(4):643-654
pubmed: 29453313
N Engl J Med. 2016 Aug 4;375(5):443-53
pubmed: 27433846
Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2058-63
pubmed: 21233418
Cell Death Dis. 2012 Aug 16;3:e371
pubmed: 22898869
Prostate. 1995 Jun;26(6):310-5
pubmed: 7784270
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18012-7
pubmed: 15604152